European Journal of Cancer
Volume 46, Issue 5 , Pages 885-891, March 2010

A randomised phase II study of combination chemotherapy with epirubicin, cisplatin and capecitabine (ECX) or cisplatin and capecitabine (CX) in advanced gastric cancer

Division of Hematology-Oncology, Department of Medicine, Sungkyunkwan University Samsung Medical Center, Seoul 135-710, Republic of Korea

Received 14 November 2009; received in revised form 5 December 2009; accepted 9 December 2009. published online 08 January 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0959-8049(09)00927-7

doi:10.1016/j.ejca.2009.12.015

European Journal of Cancer
Volume 46, Issue 5 , Pages 885-891, March 2010

Article Tools

* Image Usage & Resolution